Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 2.608 27 days ( -27.96 % )
Last Price 43.70€ 1.63 %
High/ Low 42.90€ - 43.80€ 0.233%
Chg 7 Days -0.228 % $43.80 43.70€
Chg 30 Days 18.11 % $37.00 43.70€
Chg 12 mos 58.62 % $27.55 43.70€
Trend - 3 mos 51.04 % Width: 14.26 %
Trend - 12 mos 35.77 % Width: 38.99 %
Pred. range - 3 mos 61.79€ - 70.60€ 41.39 % - 61.55 %
Pred. range - 12 mos 44.18€ - 61.41€ 1.10 % - 40.52 %
Short MA avg 3 mos Buy May 07, 2024 - 2 days
Long MA avg 3 mos Buy Feb 27, 2024 - 49 days
Short/Long MA avg 3 mos Buy Mar 01, 2024 - 46 days
Short MA avg 12 mos Sell Mar 26, 2024 - 29 days
Long MA avg 12 mos Buy Mar 04, 2024 - 45 days
Short/Long MA avg 12 mos Buy Mar 18, 2024 - 35 days
Pivot Short Sell Apr 26, 2024 - 8 days
Bollinger Buy Apr 12, 2024 - 18 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Deutsche Rohstoff AG

Deutsche Rohstoff AG Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... DR0.F Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT